Meningococcal vaccine - AchilleS Vaccines/University of Cambridge
Alternative Names: MenOMVax; Multivalent universal pan-meningococcal vaccine - AchilleS VaccinesLatest Information Update: 02 Oct 2021
At a glance
- Originator AchilleS Vaccines
- Developer AchilleS Vaccines; University of Cambridge
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Meningococcal infections